Skip to content

Effects of Rhinopharyngeal Retrograde Clearance in Children With Acute Viral Bronchiolitis

Comparison Between Rhinopharyngeal Retrograde Clearance and Nasopharyngeal Aspiration in Children With Acute Viral Bronchiolitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02460614
Enrollment
100
Registered
2015-06-02
Start date
2013-03-31
Completion date
2013-12-31
Last updated
2015-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Viral Bronchiolitis

Keywords

bronchiolitis, respiratory physiotherapy, pediatrics, rhinopharyngeal clearance

Brief summary

The purpose of this study is to compare the immediate effects of retrograde rhinopharyngeal clearance with nasopharyngeal aspiration in children admitted with acute viral bronchiolitis. The investigators selected children, up to 12 months old, admitted for acute viral bronchiolitis. Patients were divided in aspiration group (AG), submitted to nasopharyngeal aspiration, and clearance group (CG), submitted to retrograde rhinopharyngeal clearance with physiological solution (0.9%) instillation (RRC) technique. In both groups children were evaluated three times in the same day in order to verify cardiorespiratory parameters, clinical score of respiratory dysfunction and adverse effects.

Detailed description

Children up to 12 months old, admitted for acute viral acute viral bronchiolitis were selected. All children participating in the study should be in the first 48 hours of hospitalization. Patients were divided in aspiration group (AG), submitted to nasopharyngeal aspiration, and clearance group (CG), submitted to retrograde rhinopharyngeal clearance (RRC) technique with physiological solution (0.9%) instillation. In both groups children were evaluated three times in the same day (data collection 1 (C1) - performed early in the morning; data collecting 2 (C2) - performed in the early afternoon; and data collecting 3 (C3) - performed in the evening). In each data collection, cardiorespiratory parameters and clinical score of respiratory dysfunction were evaluated before procedures (T0), 10 minutes after (T1) and 30 minutes after (T2). Adverse effects were evaluated during the whole day of the study.

Interventions

PROCEDURERhinopharyngeal clearance

At the end of the expiratory time, the child's mouth was closed by the hand of the researcher (raising the lower jaw), leading the child to perform a nasal aspiration maneuver.

PROCEDUREAspiration

A sterile aspiration catheter was connected to an extension and carefully introduced into the nasal cavity of the patient.

OTHER0.9% saline

0.9% saline consists of physiological solution and was instilled in both experimental groups.

Sponsors

Pontificia Universidade Católica do Rio Grande do Sul
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 12 Months
Healthy volunteers
No

Inclusion criteria

* acute viral bronchiolitis diagnosis * indication for hospital admission

Exclusion criteria

* history of lung disease related to prematurity (bronchopulmonary dysplasia) * heart diseases * chronic lung diseases (cystic fibrosis) * pneumonia * unstable hemodynamic process (ARDS or sepsis) * subcutaneous edema * admission to the intensive care unit * need for mechanical ventilation or tracheostomy * neurological diseases

Design outcomes

Primary

MeasureTime frame
Number of vomit episodes as a measure of adverse effects1 day
Occurrence of chest retractions as a measure of respiratory distress30 minutes
Occurrence of wheezing as a measure of respiratory distress30 minutes
Number of nasal bleeding events as a measure of adverse effects1 day

Secondary

MeasureTime frame
Measurement of the heart rate using an oximeter30 minutes
Measurement of the respiratory rate30 minutes
Measurement of the oxygen saturation using an oximeter30 minutes
Severity scores on the Wood clinical score30 minutes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026